期刊
REGENERATIVE MEDICINE
卷 11, 期 6, 页码 571-587出版社
FUTURE MEDICINE LTD
DOI: 10.2217/rme-2016-0042
关键词
3D printing; additive manufacturing; biomaterials; bioreactor; bone tissue engineering; cell-based therapy
资金
- NIH [R01-DE013740, R01-AR061460]
- Army, Navy, NIH, Air Force, VA, and Health Affairs [W81XWH-14-2-0004]
- US Army Medical Research Acquisition Activity [W81XWH-14-2-0004]
- 3DBioResins (Pepper Pike, OH, USA)
- 3DServicePros, LLC (Pepper Pike, OH, USA)
- Osteoplastics, LLC
Bone tissue engineering (BTE) intends to restore structural support for movement and mineral homeostasis, and assist in hematopoiesis and the protective functions of bone in traumatic, degenerative, cancer, or congenital malformation. While much effort has been put into BTE, very little of this research has been translated to the clinic. In this review, we discuss current regenerative medicine and restorative strategies that utilize tissue engineering approaches to address bone defects within a clinical setting. These approaches involve the primary components of tissue engineering: cells, growth factors and biomaterials discussed briefly in light of their clinical relevance. This review also presents upcoming advanced approaches for BTE applications and suggests a probable workpath for translation from the laboratory to the clinic.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据